Department of Anaesthesia and Critical Care Medicine, St. James's Hospital, James's Street, Dublin 8, Ireland.
Department of Anaesthesia and Critical Care Medicine, St. James's Hospital, James's Street, Dublin 8, Ireland; Department of Anesthesia and Intensive Care Medicine, Università Cattolica del Sacro Cuore-Fondazione Policlinico Universitario A.Gemelli, Largo Agostino Gemelli 8, Rome 00168, Italy.
Clin Chest Med. 2018 Dec;39(4):785-796. doi: 10.1016/j.ccm.2018.08.003.
Ventilator-associated tracheobronchitis (VAT) might represent an intermediate process between lower respiratory tract colonization and ventilator-associated pneumonia (VAP), or even a less severe spectrum of VAP. There is an urgent need for new concepts in the arena of ventilator-associated lower respiratory tract infections. Ideally, the gold standard of care is based on prevention rather than treatment of respiratory infection. However, despite numerous and sometimes imaginative efforts to validate the benefit of these measures, most clinicians now accept that currently available measures have failed to eradicate VAP. Stopping the progression from VAT to VAP could improve patient outcomes.
呼吸机相关性气管支气管炎(VAT)可能代表下呼吸道定植与呼吸机相关性肺炎(VAP)之间的中间过程,甚至是 VAP 较轻的一个谱。呼吸机相关性下呼吸道感染领域急需新概念。理想情况下,以预防而非治疗呼吸道感染为基础的护理金标准。然而,尽管为验证这些措施的益处进行了大量有时富有想象力的努力,但大多数临床医生现在都接受了一个事实,即目前可用的措施未能根除 VAP。阻止 VAT 向 VAP 的进展可能会改善患者的预后。